Ventyx Biosciences
VTYX | NASDAQ
$14.00
$0.00 (0.00%)
At close: Mar 3, 2026, 4:00 PM ET
+0.00%
(1D)No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Market Cap $1B
1D Range
14.00 14.00
52W Range
0.78 25.00
Valuation (TTM)
PE -9.33
PB 5.25
EV/EBITDA -7.79
Valuation (NTM)
Forward PE N/A
Forward PEG -0.98
Price Target $26.78
Cash Flow
FCF Yield -8.8%
SBC Adj. FCF Yield -10.7%
SBC Impact -22.1%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 33.8% |
-0.8%
FCF 3Y | 5Y 27.3% |
-21.6%
Returns
ROA -23.6%
ROE -24.9%
ROIC -26.9%
Financial Health
Net Cash
$192.64M
Current Ratio 17.86
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Ventyx Biosciences, Inc. is a biopharmaceutical company in the clinical development phase, specializing in the creation of small molecule therapeutics for inflammatory and autoimmune disorders. The co...
Sector Healthcare
Industry Biotechnology
Employees 81
IPO Date Oct 21, 2021
Website www.lilly.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
6
Consensus
Hold
Price Target
$14.00
Upside
0.00%
Buy (0)
Hold (5)
Sell (0)
Add to Watchlist
Select watchlists to add or remove VTYX